| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2023 | 15.02% | JP Morgan | $108 → $99 | Maintains | Overweight |
| 11/09/2023 | 28.96% | Barrington Research | $124 → $111 | Maintains | Outperform |
| 09/22/2023 | 25.48% | JP Morgan | → $108 | Initiates Coverage On | → Overweight |
| 09/19/2023 | — | CJS Securities | Upgrades | Market Perform → Market Outperform | |
| 08/14/2023 | 44.07% | Barrington Research | $116 → $124 | Maintains | Outperform |
| 06/30/2023 | 60.33% | B of A Securities | → $138 | Initiates Coverage On | → Buy |
| 05/05/2023 | 34.77% | Barrington Research | $110 → $116 | Maintains | Outperform |
| 02/24/2023 | 27.8% | Barrington Research | $107 → $110 | Maintains | Outperform |
| 12/14/2021 | 39.42% | CJS Securities | → $120 | Upgrades | Market Perform → Market Outperform |
| 05/07/2021 | 51.04% | Barrington Research | → $130 | Upgrades | Market Perform → Outperform |
| 05/03/2021 | 56.85% | Jefferies | $130 → $135 | Upgrades | Hold → Buy |
| 02/26/2021 | — | Barrington Research | Downgrades | Outperform → Market Perform | |
| 03/27/2020 | -7.05% | Sidoti & Co. | $128 → $80 | Maintains | Buy |
| 11/08/2019 | 51.04% | Barrington Research | → $130 | Upgrades | Market Perform → Outperform |
| 03/08/2019 | — | William Blair | Initiates Coverage On | → Outperform |
What is the target price for US Physical Therapy (USPH)?
The latest price target for US Physical Therapy (NYSE: USPH) was reported by JP Morgan on November 17, 2023. The analyst firm set a price target for $99.00 expecting USPH to rise to within 12 months (a possible 15.02% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for US Physical Therapy (USPH)?
The latest analyst rating for US Physical Therapy (NYSE: USPH) was provided by JP Morgan, and US Physical Therapy maintained their overweight rating.
When is the next analyst rating going to be posted or updated for US Physical Therapy (USPH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of US Physical Therapy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for US Physical Therapy was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
Is the Analyst Rating US Physical Therapy (USPH) correct?
While ratings are subjective and will change, the latest US Physical Therapy (USPH) rating was a maintained with a price target of $108.00 to $99.00. The current price US Physical Therapy (USPH) is trading at is $86.07, which is out of the analyst's predicted range.